Episode
Episode 191 - Trevor Martin - Co-Founder & CEO Mammoth Biosciences
- Podcast
- The BioHub - by Avetix
- Published
- Jun 19, 2026
- Duration seconds
- 1136
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-191-trevor-martin-co-founder-ceo-mammoth-biosciences/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-191-trevor-martin-co-founder-ceo-mammoth-biosciences.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of The BioHub, Amber is joined by Trevor Martin, Co-Founder and CEO of Mammoth Biosciences. Mammoth Biosciences is developing next-generation CRISPR technologies with the goal of unlocking the full potential of programmable medicine. Founded alongside Nobel Prize winner Jennifer Doudna, the company has built a platform focused on discovering and engineering novel CRISPR systems for both diagnostic and therapeutic applications. During the conversation, Trevor shares the story behind Mammoth's founding, the evolution of the CRISPR field, and why delivery remains one of the biggest challenges in gene editing today. We also discuss the transition from platform innovation to therapeutic development, the role of AI and computational biology in advancing gene editing technologies, and what the future of programmable medicine may look like.